The global market for Injection Human Interleukin-2 is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Injection Human Interleukin-2 market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Injection Human Interleukin-2 market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Injection Human Interleukin-2 market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Injection Human Interleukin-2 market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Injection Human Interleukin-2 players cover Clinigen, 3SBio, Beijing Four Rings Biopharmaceutical, Jiangsu Kingsley Pharmaceutical and Beijing Yuance Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Injection Human Interleukin-2 market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Injection Human Interleukin-2 market, with both quantitative and qualitative data, to help readers understand how the Injection Human Interleukin-2 market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Injection Human Interleukin-2 market and forecasts the market size by Type (50000 IU, 100000 IU and 200000 IU), by Application (Hospital and Pharmacy.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
50000 IU
100000 IU
200000 IU
500000 IU
1 Million IU
Other
Segmentation by application
Hospital
Pharmacy
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Clinigen
3SBio
Beijing Four Rings Biopharmaceutical
Jiangsu Kingsley Pharmaceutical
Beijing Yuance Pharmaceutical
Beijing SL Pharm
Shanghai Huaxin Biotechnology
Changchun Institute Of Biological Products
Shandong Quangang Pharmaceutical
Chapter Introduction
Chapter 1: Scope of Injection Human Interleukin-2, Research Methodology, etc.
Chapter 2: Executive Summary, global Injection Human Interleukin-2 market size (sales and revenue) and CAGR, Injection Human Interleukin-2 market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Injection Human Interleukin-2 sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Injection Human Interleukin-2 sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Injection Human Interleukin-2 market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Clinigen, 3SBio, Beijing Four Rings Biopharmaceutical, Jiangsu Kingsley Pharmaceutical, Beijing Yuance Pharmaceutical, Beijing SL Pharm, Shanghai Huaxin Biotechnology, Changchun Institute Of Biological Products and Shandong Quangang Pharmaceutical. etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Injection Human Interleukin-2 Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Injection Human Interleukin-2 by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Injection Human Interleukin-2 by Country/Region, 2017, 2022 & 2028
2.2 Injection Human Interleukin-2 Segment by Type
2.2.1 50000 IU
2.2.2 100000 IU
2.2.3 200000 IU
2.2.4 500000 IU
2.2.5 1 Million IU
2.2.6 Other
2.3 Injection Human Interleukin-2 Sales by Type
2.3.1 Global Injection Human Interleukin-2 Sales Market Share by Type (2017-2022)
2.3.2 Global Injection Human Interleukin-2 Revenue and Market Share by Type (2017-2022)
2.3.3 Global Injection Human Interleukin-2 Sale Price by Type (2017-2022)
2.4 Injection Human Interleukin-2 Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Injection Human Interleukin-2 Sales by Application
2.5.1 Global Injection Human Interleukin-2 Sale Market Share by Application (2017-2022)
2.5.2 Global Injection Human Interleukin-2 Revenue and Market Share by Application (2017-2022)
2.5.3 Global Injection Human Interleukin-2 Sale Price by Application (2017-2022)
3 Global Injection Human Interleukin-2 by Company
3.1 Global Injection Human Interleukin-2 Breakdown Data by Company
3.1.1 Global Injection Human Interleukin-2 Annual Sales by Company (2020-2022)
3.1.2 Global Injection Human Interleukin-2 Sales Market Share by Company (2020-2022)
3.2 Global Injection Human Interleukin-2 Annual Revenue by Company (2020-2022)
3.2.1 Global Injection Human Interleukin-2 Revenue by Company (2020-2022)
3.2.2 Global Injection Human Interleukin-2 Revenue Market Share by Company (2020-2022)
3.3 Global Injection Human Interleukin-2 Sale Price by Company
3.4 Key Manufacturers Injection Human Interleukin-2 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Injection Human Interleukin-2 Product Location Distribution
3.4.2 Players Injection Human Interleukin-2 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Injection Human Interleukin-2 by Geographic Region
4.1 World Historic Injection Human Interleukin-2 Market Size by Geographic Region (2017-2022)
4.1.1 Global Injection Human Interleukin-2 Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Injection Human Interleukin-2 Annual Revenue by Geographic Region
4.2 World Historic Injection Human Interleukin-2 Market Size by Country/Region (2017-2022)
4.2.1 Global Injection Human Interleukin-2 Annual Sales by Country/Region (2017-2022)
4.2.2 Global Injection Human Interleukin-2 Annual Revenue by Country/Region
4.3 Americas Injection Human Interleukin-2 Sales Growth
4.4 APAC Injection Human Interleukin-2 Sales Growth
4.5 Europe Injection Human Interleukin-2 Sales Growth
4.6 Middle East & Africa Injection Human Interleukin-2 Sales Growth
5 Americas
5.1 Americas Injection Human Interleukin-2 Sales by Country
5.1.1 Americas Injection Human Interleukin-2 Sales by Country (2017-2022)
5.1.2 Americas Injection Human Interleukin-2 Revenue by Country (2017-2022)
5.2 Americas Injection Human Interleukin-2 Sales by Type
5.3 Americas Injection Human Interleukin-2 Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Injection Human Interleukin-2 Sales by Region
6.1.1 APAC Injection Human Interleukin-2 Sales by Region (2017-2022)
6.1.2 APAC Injection Human Interleukin-2 Revenue by Region (2017-2022)
6.2 APAC Injection Human Interleukin-2 Sales by Type
6.3 APAC Injection Human Interleukin-2 Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Injection Human Interleukin-2 by Country
7.1.1 Europe Injection Human Interleukin-2 Sales by Country (2017-2022)
7.1.2 Europe Injection Human Interleukin-2 Revenue by Country (2017-2022)
7.2 Europe Injection Human Interleukin-2 Sales by Type
7.3 Europe Injection Human Interleukin-2 Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Injection Human Interleukin-2 by Country
8.1.1 Middle East & Africa Injection Human Interleukin-2 Sales by Country (2017-2022)
8.1.2 Middle East & Africa Injection Human Interleukin-2 Revenue by Country (2017-2022)
8.2 Middle East & Africa Injection Human Interleukin-2 Sales by Type
8.3 Middle East & Africa Injection Human Interleukin-2 Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Injection Human Interleukin-2
10.3 Manufacturing Process Analysis of Injection Human Interleukin-2
10.4 Industry Chain Structure of Injection Human Interleukin-2
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Injection Human Interleukin-2 Distributors
11.3 Injection Human Interleukin-2 Customer
12 World Forecast Review for Injection Human Interleukin-2 by Geographic Region
12.1 Global Injection Human Interleukin-2 Market Size Forecast by Region
12.1.1 Global Injection Human Interleukin-2 Forecast by Region (2023-2028)
12.1.2 Global Injection Human Interleukin-2 Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Injection Human Interleukin-2 Forecast by Type
12.7 Global Injection Human Interleukin-2 Forecast by Application
13 Key Players Analysis
13.1 Clinigen
13.1.1 Clinigen Company Information
13.1.2 Clinigen Injection Human Interleukin-2 Product Offered
13.1.3 Clinigen Injection Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Clinigen Main Business Overview
13.1.5 Clinigen Latest Developments
13.2 3SBio
13.2.1 3SBio Company Information
13.2.2 3SBio Injection Human Interleukin-2 Product Offered
13.2.3 3SBio Injection Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 3SBio Main Business Overview
13.2.5 3SBio Latest Developments
13.3 Beijing Four Rings Biopharmaceutical
13.3.1 Beijing Four Rings Biopharmaceutical Company Information
13.3.2 Beijing Four Rings Biopharmaceutical Injection Human Interleukin-2 Product Offered
13.3.3 Beijing Four Rings Biopharmaceutical Injection Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Beijing Four Rings Biopharmaceutical Main Business Overview
13.3.5 Beijing Four Rings Biopharmaceutical Latest Developments
13.4 Jiangsu Kingsley Pharmaceutical
13.4.1 Jiangsu Kingsley Pharmaceutical Company Information
13.4.2 Jiangsu Kingsley Pharmaceutical Injection Human Interleukin-2 Product Offered
13.4.3 Jiangsu Kingsley Pharmaceutical Injection Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Jiangsu Kingsley Pharmaceutical Main Business Overview
13.4.5 Jiangsu Kingsley Pharmaceutical Latest Developments
13.5 Beijing Yuance Pharmaceutical
13.5.1 Beijing Yuance Pharmaceutical Company Information
13.5.2 Beijing Yuance Pharmaceutical Injection Human Interleukin-2 Product Offered
13.5.3 Beijing Yuance Pharmaceutical Injection Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Beijing Yuance Pharmaceutical Main Business Overview
13.5.5 Beijing Yuance Pharmaceutical Latest Developments
13.6 Beijing SL Pharm
13.6.1 Beijing SL Pharm Company Information
13.6.2 Beijing SL Pharm Injection Human Interleukin-2 Product Offered
13.6.3 Beijing SL Pharm Injection Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Beijing SL Pharm Main Business Overview
13.6.5 Beijing SL Pharm Latest Developments
13.7 Shanghai Huaxin Biotechnology
13.7.1 Shanghai Huaxin Biotechnology Company Information
13.7.2 Shanghai Huaxin Biotechnology Injection Human Interleukin-2 Product Offered
13.7.3 Shanghai Huaxin Biotechnology Injection Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Shanghai Huaxin Biotechnology Main Business Overview
13.7.5 Shanghai Huaxin Biotechnology Latest Developments
13.8 Changchun Institute Of Biological Products
13.8.1 Changchun Institute Of Biological Products Company Information
13.8.2 Changchun Institute Of Biological Products Injection Human Interleukin-2 Product Offered
13.8.3 Changchun Institute Of Biological Products Injection Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Changchun Institute Of Biological Products Main Business Overview
13.8.5 Changchun Institute Of Biological Products Latest Developments
13.9 Shandong Quangang Pharmaceutical
13.9.1 Shandong Quangang Pharmaceutical Company Information
13.9.2 Shandong Quangang Pharmaceutical Injection Human Interleukin-2 Product Offered
13.9.3 Shandong Quangang Pharmaceutical Injection Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Shandong Quangang Pharmaceutical Main Business Overview
13.9.5 Shandong Quangang Pharmaceutical Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Injection Human Interleukin-2 Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Injection Human Interleukin-2 Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 50000 IU
Table 4. Major Players of 100000 IU
Table 5. Major Players of 200000 IU
Table 6. Major Players of 500000 IU
Table 7. Major Players of 1 Million IU
Table 8. Major Players of Other
Table 9. Global Injection Human Interleukin-2 Sales by Type (2017-2022) & (K Units)
Table 10. Global Injection Human Interleukin-2 Sales Market Share by Type (2017-2022)
Table 11. Global Injection Human Interleukin-2 Revenue by Type (2017-2022) & ($ million)
Table 12. Global Injection Human Interleukin-2 Revenue Market Share by Type (2017-2022)
Table 13. Global Injection Human Interleukin-2 Sale Price by Type (2017-2022) & (US$/Unit)
Table 14. Global Injection Human Interleukin-2 Sales by Application (2017-2022) & (K Units)
Table 15. Global Injection Human Interleukin-2 Sales Market Share by Application (2017-2022)
Table 16. Global Injection Human Interleukin-2 Revenue by Application (2017-2022)
Table 17. Global Injection Human Interleukin-2 Revenue Market Share by Application (2017-2022)
Table 18. Global Injection Human Interleukin-2 Sale Price by Application (2017-2022) & (US$/Unit)
Table 19. Global Injection Human Interleukin-2 Sales by Company (2020-2022) & (K Units)
Table 20. Global Injection Human Interleukin-2 Sales Market Share by Company (2020-2022)
Table 21. Global Injection Human Interleukin-2 Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Injection Human Interleukin-2 Revenue Market Share by Company (2020-2022)
Table 23. Global Injection Human Interleukin-2 Sale Price by Company (2020-2022) & (US$/Unit)
Table 24. Key Manufacturers Injection Human Interleukin-2 Producing Area Distribution and Sales Area
Table 25. Players Injection Human Interleukin-2 Products Offered
Table 26. Injection Human Interleukin-2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Injection Human Interleukin-2 Sales by Geographic Region (2017-2022) & (K Units)
Table 30. Global Injection Human Interleukin-2 Sales Market Share Geographic Region (2017-2022)
Table 31. Global Injection Human Interleukin-2 Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Injection Human Interleukin-2 Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Injection Human Interleukin-2 Sales by Country/Region (2017-2022) & (K Units)
Table 34. Global Injection Human Interleukin-2 Sales Market Share by Country/Region (2017-2022)
Table 35. Global Injection Human Interleukin-2 Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Injection Human Interleukin-2 Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Injection Human Interleukin-2 Sales by Country (2017-2022) & (K Units)
Table 38. Americas Injection Human Interleukin-2 Sales Market Share by Country (2017-2022)
Table 39. Americas Injection Human Interleukin-2 Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Injection Human Interleukin-2 Revenue Market Share by Country (2017-2022)
Table 41. Americas Injection Human Interleukin-2 Sales by Type (2017-2022) & (K Units)
Table 42. Americas Injection Human Interleukin-2 Sales Market Share by Type (2017-2022)
Table 43. Americas Injection Human Interleukin-2 Sales by Application (2017-2022) & (K Units)
Table 44. Americas Injection Human Interleukin-2 Sales Market Share by Application (2017-2022)
Table 45. APAC Injection Human Interleukin-2 Sales by Region (2017-2022) & (K Units)
Table 46. APAC Injection Human Interleukin-2 Sales Market Share by Region (2017-2022)
Table 47. APAC Injection Human Interleukin-2 Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Injection Human Interleukin-2 Revenue Market Share by Region (2017-2022)
Table 49. APAC Injection Human Interleukin-2 Sales by Type (2017-2022) & (K Units)
Table 50. APAC Injection Human Interleukin-2 Sales Market Share by Type (2017-2022)
Table 51. APAC Injection Human Interleukin-2 Sales by Application (2017-2022) & (K Units)
Table 52. APAC Injection Human Interleukin-2 Sales Market Share by Application (2017-2022)
Table 53. Europe Injection Human Interleukin-2 Sales by Country (2017-2022) & (K Units)
Table 54. Europe Injection Human Interleukin-2 Sales Market Share by Country (2017-2022)
Table 55. Europe Injection Human Interleukin-2 Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Injection Human Interleukin-2 Revenue Market Share by Country (2017-2022)
Table 57. Europe Injection Human Interleukin-2 Sales by Type (2017-2022) & (K Units)
Table 58. Europe Injection Human Interleukin-2 Sales Market Share by Type (2017-2022)
Table 59. Europe Injection Human Interleukin-2 Sales by Application (2017-2022) & (K Units)
Table 60. Europe Injection Human Interleukin-2 Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Injection Human Interleukin-2 Sales by Country (2017-2022) & (K Units)
Table 62. Middle East & Africa Injection Human Interleukin-2 Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Injection Human Interleukin-2 Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Injection Human Interleukin-2 Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Injection Human Interleukin-2 Sales by Type (2017-2022) & (K Units)
Table 66. Middle East & Africa Injection Human Interleukin-2 Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Injection Human Interleukin-2 Sales by Application (2017-2022) & (K Units)
Table 68. Middle East & Africa Injection Human Interleukin-2 Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Injection Human Interleukin-2
Table 70. Key Market Challenges & Risks of Injection Human Interleukin-2
Table 71. Key Industry Trends of Injection Human Interleukin-2
Table 72. Injection Human Interleukin-2 Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Injection Human Interleukin-2 Distributors List
Table 75. Injection Human Interleukin-2 Customer List
Table 76. Global Injection Human Interleukin-2 Sales Forecast by Region (2023-2028) & (K Units)
Table 77. Global Injection Human Interleukin-2 Sales Market Forecast by Region
Table 78. Global Injection Human Interleukin-2 Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Injection Human Interleukin-2 Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Injection Human Interleukin-2 Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Americas Injection Human Interleukin-2 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Injection Human Interleukin-2 Sales Forecast by Region (2023-2028) & (K Units)
Table 83. APAC Injection Human Interleukin-2 Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Injection Human Interleukin-2 Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Europe Injection Human Interleukin-2 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Injection Human Interleukin-2 Sales Forecast by Country (2023-2028) & (K Units)
Table 87. Middle East & Africa Injection Human Interleukin-2 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Injection Human Interleukin-2 Sales Forecast by Type (2023-2028) & (K Units)
Table 89. Global Injection Human Interleukin-2 Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Injection Human Interleukin-2 Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Injection Human Interleukin-2 Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Injection Human Interleukin-2 Sales Forecast by Application (2023-2028) & (K Units)
Table 93. Global Injection Human Interleukin-2 Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Injection Human Interleukin-2 Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Injection Human Interleukin-2 Revenue Market Share Forecast by Application (2023-2028)
Table 96. Clinigen Basic Information, Injection Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 97. Clinigen Injection Human Interleukin-2 Product Offered
Table 98. Clinigen Injection Human Interleukin-2 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 99. Clinigen Main Business
Table 100. Clinigen Latest Developments
Table 101. 3SBio Basic Information, Injection Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 102. 3SBio Injection Human Interleukin-2 Product Offered
Table 103. 3SBio Injection Human Interleukin-2 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 104. 3SBio Main Business
Table 105. 3SBio Latest Developments
Table 106. Beijing Four Rings Biopharmaceutical Basic Information, Injection Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 107. Beijing Four Rings Biopharmaceutical Injection Human Interleukin-2 Product Offered
Table 108. Beijing Four Rings Biopharmaceutical Injection Human Interleukin-2 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 109. Beijing Four Rings Biopharmaceutical Main Business
Table 110. Beijing Four Rings Biopharmaceutical Latest Developments
Table 111. Jiangsu Kingsley Pharmaceutical Basic Information, Injection Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 112. Jiangsu Kingsley Pharmaceutical Injection Human Interleukin-2 Product Offered
Table 113. Jiangsu Kingsley Pharmaceutical Injection Human Interleukin-2 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 114. Jiangsu Kingsley Pharmaceutical Main Business
Table 115. Jiangsu Kingsley Pharmaceutical Latest Developments
Table 116. Beijing Yuance Pharmaceutical Basic Information, Injection Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 117. Beijing Yuance Pharmaceutical Injection Human Interleukin-2 Product Offered
Table 118. Beijing Yuance Pharmaceutical Injection Human Interleukin-2 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 119. Beijing Yuance Pharmaceutical Main Business
Table 120. Beijing Yuance Pharmaceutical Latest Developments
Table 121. Beijing SL Pharm Basic Information, Injection Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 122. Beijing SL Pharm Injection Human Interleukin-2 Product Offered
Table 123. Beijing SL Pharm Injection Human Interleukin-2 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 124. Beijing SL Pharm Main Business
Table 125. Beijing SL Pharm Latest Developments
Table 126. Shanghai Huaxin Biotechnology Basic Information, Injection Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 127. Shanghai Huaxin Biotechnology Injection Human Interleukin-2 Product Offered
Table 128. Shanghai Huaxin Biotechnology Injection Human Interleukin-2 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 129. Shanghai Huaxin Biotechnology Main Business
Table 130. Shanghai Huaxin Biotechnology Latest Developments
Table 131. Changchun Institute Of Biological Products Basic Information, Injection Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 132. Changchun Institute Of Biological Products Injection Human Interleukin-2 Product Offered
Table 133. Changchun Institute Of Biological Products Injection Human Interleukin-2 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 134. Changchun Institute Of Biological Products Main Business
Table 135. Changchun Institute Of Biological Products Latest Developments
Table 136. Shandong Quangang Pharmaceutical Basic Information, Injection Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 137. Shandong Quangang Pharmaceutical Injection Human Interleukin-2 Product Offered
Table 138. Shandong Quangang Pharmaceutical Injection Human Interleukin-2 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 139. Shandong Quangang Pharmaceutical Main Business
Table 140. Shandong Quangang Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Injection Human Interleukin-2
Figure 2. Injection Human Interleukin-2 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Injection Human Interleukin-2 Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Injection Human Interleukin-2 Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Injection Human Interleukin-2 Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 50000 IU
Figure 10. Product Picture of 100000 IU
Figure 11. Product Picture of 200000 IU
Figure 12. Product Picture of 500000 IU
Figure 13. Product Picture of 1 Million IU
Figure 14. Product Picture of Other
Figure 15. Global Injection Human Interleukin-2 Sales Market Share by Type in 2021
Figure 16. Global Injection Human Interleukin-2 Revenue Market Share by Type (2017-2022)
Figure 17. Injection Human Interleukin-2 Consumed in Hospital
Figure 18. Global Injection Human Interleukin-2 Market: Hospital (2017-2022) & (K Units)
Figure 19. Injection Human Interleukin-2 Consumed in Pharmacy
Figure 20. Global Injection Human Interleukin-2 Market: Pharmacy (2017-2022) & (K Units)
Figure 21. Global Injection Human Interleukin-2 Sales Market Share by Application (2017-2022)
Figure 22. Global Injection Human Interleukin-2 Revenue Market Share by Application in 2021
Figure 23. Injection Human Interleukin-2 Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Injection Human Interleukin-2 Revenue Market Share by Company in 2021
Figure 25. Global Injection Human Interleukin-2 Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Injection Human Interleukin-2 Revenue Market Share by Geographic Region in 2021
Figure 27. Global Injection Human Interleukin-2 Sales Market Share by Region (2017-2022)
Figure 28. Global Injection Human Interleukin-2 Revenue Market Share by Country/Region in 2021
Figure 29. Americas Injection Human Interleukin-2 Sales 2017-2022 (K Units)
Figure 30. Americas Injection Human Interleukin-2 Revenue 2017-2022 ($ Millions)
Figure 31. APAC Injection Human Interleukin-2 Sales 2017-2022 (K Units)
Figure 32. APAC Injection Human Interleukin-2 Revenue 2017-2022 ($ Millions)
Figure 33. Europe Injection Human Interleukin-2 Sales 2017-2022 (K Units)
Figure 34. Europe Injection Human Interleukin-2 Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Injection Human Interleukin-2 Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Injection Human Interleukin-2 Revenue 2017-2022 ($ Millions)
Figure 37. Americas Injection Human Interleukin-2 Sales Market Share by Country in 2021
Figure 38. Americas Injection Human Interleukin-2 Revenue Market Share by Country in 2021
Figure 39. United States Injection Human Interleukin-2 Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Injection Human Interleukin-2 Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Injection Human Interleukin-2 Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Injection Human Interleukin-2 Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Injection Human Interleukin-2 Sales Market Share by Region in 2021
Figure 44. APAC Injection Human Interleukin-2 Revenue Market Share by Regions in 2021
Figure 45. China Injection Human Interleukin-2 Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Injection Human Interleukin-2 Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Injection Human Interleukin-2 Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Injection Human Interleukin-2 Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Injection Human Interleukin-2 Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Injection Human Interleukin-2 Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Injection Human Interleukin-2 Sales Market Share by Country in 2021
Figure 52. Europe Injection Human Interleukin-2 Revenue Market Share by Country in 2021
Figure 53. Germany Injection Human Interleukin-2 Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Injection Human Interleukin-2 Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Injection Human Interleukin-2 Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Injection Human Interleukin-2 Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Injection Human Interleukin-2 Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Injection Human Interleukin-2 Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Injection Human Interleukin-2 Revenue Market Share by Country in 2021
Figure 60. Egypt Injection Human Interleukin-2 Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Injection Human Interleukin-2 Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Injection Human Interleukin-2 Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Injection Human Interleukin-2 Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Injection Human Interleukin-2 Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Injection Human Interleukin-2 in 2021
Figure 66. Manufacturing Process Analysis of Injection Human Interleukin-2
Figure 67. Industry Chain Structure of Injection Human Interleukin-2
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)